Rosa Krajmalnik‐Brown

This study shows that acute aflatoxin B1 exposure does not significantly alter human gut microbiota composition or function, with observed changes attributed to solvent effects rather than direct toxin impact.

This study shows that DMSO significantly alters gut microbiota metabolism and enriches Desulfovibrio desulfuricans, overshadowing xenobiotic effects.

The paper identifies distinct gut microbial and body composition signatures associated with different growth trajectories in South African infants during their first year of life.

Oral Faecalibacterium prausnitzii, the taxon most consistently depleted in PD stool, improved motor and GI deficits and lowered α-synuclein aggregates in male Thy1-ASO mice.

This study identifies a gut microbial sulfotransferase that sulfonates diverse phenolic compounds, including acetaminophen sulfate, suggesting microbial enzymes may contribute to host detoxification.

This study uses metatranscriptomic data to analyze how dietary composition affects gut microbiota function, finding that a fiber-rich diet promotes beneficial metabolic pathways while a low-fiber diet increases harmful protein and mucin degradation.

This study uses multi-omics analysis to identify key biological changes in ASD children after microbiota transplant therapy, showing shifts in microbiome, metabolites, and symptoms.

This study investigates the relationship between methanogens and human metabolizable energy, finding that high CH4 producers have greater serum propionate and host ME, and a network link between methanogens and fiber-degrading bacteria.

The paper reanalyzes metabolomics data from ASD patients before and after MTT using updated annotations and statistical methods, revealing metabolic changes associated with the therapy.